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A solitary ﬁbrous tumor (SFT) of the liver is a rare neoplasm of mesenchymal origin. 59 cases have been
reported in the literature. We report 2 patients who presented with a hepatic solitary ﬁbrous tumor. The
ﬁrst case is a 65-year-old man who presented with an accidental ﬁnding of a large mass in the left liver.
Biopsy revealed an SFT and left hepatectomy was performed. The diagnosis was conﬁrmed by histopa-
thology. The second case is an 87-year-old woman who presented with disturbances in her liver function
tests. A Computed Tomography (CT) scan showed a large mass in the right liver. Surgery was contra-
indicated because of the patient's poor general condition. A biopsy was done and SFT was diagnosed
histopathologically. SFT are usually benign but the risk of malignant transformation always exists, which
mandates surgical resection as the optimal management of these tumors. However, because of the small
sample size and the rarity of the entity, it is difﬁcult to deﬁne the evolution, the risk factors and the
malignant potential of these tumors.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
A solitary ﬁbrous tumor is a rare neoplasm which composes of
spindle cells and interspersed collagen. It is usually found in the
thoracic cavity and the pleura. Rarely, it is found in the medias-
tinum, skin, meninges, orbit, upper respiratory tract, breast, thyroid
and peritoneum. The hepatic location is extremely rare, and to the
best of our knowledge, only 59 cases have been described in the
medical literature. Although most SFT have benign behavior, some
may have malignant features including metastatic spread and local
recurrence [1,2]. The clinical presentation is usually mild and nongestive et Centre de Trans-
int Antoine de Ginestiere, BP
by Elsevier Ltd. All rights reservedspeciﬁc, with some patients being asymptomatic and some pre-
senting with abdominal pain, distension, dyspepsia, and other non
speciﬁc symptoms like weight loss, nausea and vomiting. The
clinical manifestation is affected by the size and the location of the
tumor [1e4].
Diagnosis of SFT is difﬁcult on imaging studies because imaging
features are non speciﬁc and do not differentiate benign from
malignant SFT. In addition, other benign and malignant tumors
such as hepatocellular carcinoma, leiomyoma, sarcoma, sclerosed
haemangioma and inﬂammatory pseudotumor may show identical
features [3,4].
Therefore, the deﬁnitive diagnosis is based on typical histo-
pathological and immunohistochemical features [5e7]. Herein we
report two cases of SFT of the liver and discuss the relative diag-
nostic and therapeutic implications..
Fig. 2. CT Scan showing a large heterogeneous mass in the right lobe of the liver.
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2.1. Case 1
A 65-year-old man was accidentally found to have a large mass
in the liver on an ultrasound carried out for an urological work up.
An abdominal Magnetic Resonance Imaging (MRI) showed a volu-
minous multilobulated mass in the left liver (Fig. 1). The mass
appeared to have hypersignal on T2 weighted images and hypo-
signal on T1 weighted images. After gadolinium injection, multiple
septations were seen enhancing in the portal and late phases. The
mass had avascular portions representing necrotic tissues. The rest
of the liver parenchymawas homogeneous. The tumor compressed
the left portal branch and was in contact with the inferior vena
cava. Biopsy of the mass showed tumoral cells demonstrating
spindle and ﬁbroblast-like cells within a collagenous stroma.
Immunohistochemistry disclosed CD34 and vimentin positivity
supporting the diagnosis of SFT. Left hepatectomy was performed
with total hepatic vascular exclusion. The middle hepatic vein was
feed from the tumor and was preserved. Grossly, the tumor was a
large encapsulated mass with well limited margins weighting
4.8 kgs. Histology revealed a fasciculated mass with absence of
necrotic or hemorrhagic degeneration. On immunohistochemistry,
the tumor cells were strongly positive for vimentin, CD34, CD99,
Bcl-2 and they were negative for Epithelial Membrane Antigen
(EMA), actin muscle, CD117, S-100, IgG4 and Dog-1. 2% of the nuclei
were positive for Ki-67. The postoperative course was complicated
by a pneumothorax that required percutaneous drainage and the
patient was discharged home on postoperative day 22. At 12
months of follow up, the patient was well and he had no signs of
recurrence.2.2. Case 2
An 87-year-old woman with a past medical history of stage IV
cardiac failure and bearer of a pacemaker was referred to our
hepatobiliary unit because a liver mass was discovered on
Computed Tomography (CT) scan which was performed for a slight
elevation in liver function tests. Alpha fetoprotein was normal. CT
scan showed a voluminous, heterogeneous, hypodense mass
occupying almost the whole of the right liver, measuring
14.6  12.3  17 cm, compressing the inferior vena cava. After
contrast injection, the mass showed clear contrast uptake with a
pseudocapsule, and pseudonecrotic zones.
There was no invasion of the portal vessels (Fig. 2). A thoracic,
cerebral and bone CT scan did not show any distant metastases. AFig. 1. MRI showing a large mass in the left liver.biopsy showed fusiforms cells without atypia, morphologic and
immunohistochemical features in favor of a hepatic solitary ﬁbrous
tumor. On immunohistochemistry, the tumor cells were strongly
positive for CD34, they were negative for PS-100, actin muscle,
CD117 and desmin. Ki-67 showed rare positive nuclei. The diagnosis
of SFT was made but no further intervention was planned as the
surgical risk was too high. At 10 months of follow up, the patient
was still alive.
3. Discussion
We were able to ﬁnd 59 cases of SFT that have been reported in
the medical literature (Table 1). On reviewing all the reported
literature, there does not seem to be a preference for these tumors
to be present on one side of the liver over the other, with 29 cases in
the right liver, 20 cases in the left liver and 10 cases were unknown.
Female predominance exists with 70% women and 30% men. The
differential diagnosis is very wide, and includes benign and ma-
lignant neoplasm [1e3]. As seen in our 2 cases, these tumors show
heterogeneous enhancement on imaging, probably because of dif-
ferential enhancement of the admixed cellular and collagenous
components. However, imaging does not differentiate between
benign and malignant tumors, as imaging features appear to
overlap [3,4]. Symptoms usually appear late, and are mainly due to
compression of nearby structures. Some patients presented with
hypoglycemia, which can be explained by a Non-islet cell tumor
hypoglycemia (NICTH), a syndrome related to paraneoplastic pro-
duction of insulin-like growth factor (IGF). Some authors have
associated the hypoglycemia to a poor prognostic sign. However,
from the 5 patients who presented with symptoms of hypoglyce-
mia, only one patient had a malignant tumor. So there does not
seem to be enough criteria to correlate between hypoglycemia and
malignancy [5,8,9]. A deﬁnitive diagnosis of SFT of the liver must
therefore be made on the basis of histopathological and immuno-
histochemical studies with a high cellular proliferation of spindle
cells arranged in a storiform pattern and with the immunohisto-
chemical staining proﬁle of CD34 (þ), vimentin (þ), Bcl-2 (þ) and
SM-actin (). These characteristics differentiate SFTs from other
liver tumors, such as primary hepatocellular carcinomas (CD34-
negative), leiomyomas (smooth-muscle actin-positive and CD34-
Table 1
Cases with SFT found in the literature.
Author Year Age/Gender Malignancy Hypoglycemia Treatment Liver IH F/up
1 Edmondson 1958 16/F N N Excision R NA 24M
2 Edmondson 1958 NA N N Excision R NA NA
3 Nevius 1959 56/M N N Radiation R NA 2D
4 Ishak 1959 56/M N N Excision L NA NA
5 Ishak 1976 62/F N N Excision L NA IOD
6 Kim 1983 27/F N N Excision L NA 6M
7 Kottke-Marchant 1989 84/F N N Excision L NA 29M
8 Kasano 1991 39/F N N Excision L NA 53M
9 Barnoud 1996 50/M N N Excision R CD34þ 38M
10 Levine 1997 57/M N N Excision L CD34þ NA
11 Guglielmi 1998 61/F N Y Excision R CD34þ 72M
12 Moran 1998 62/F N N Excision NA CD34þ NA
13 Moran 1998 34/F N N No Excision NA NA AF
14 Moran 1998 57/F N N Excision NA CD34þ NA
15 Moran 1998 32/M N N Excision NA CD34þ NA
16 Moran 1998 68/F N N Excision NA CD34þ 2D
17 Moran 1998 83/F N N Excision R CD34þ 6D
18 Moran 1998 72/F N N Excision L CD34þ 12M
19 Moran 1998 62/F N N Excision L CD34þ NA
20 Moran 1998 50/F N N Excision L CD34þ NA
21 Fuksbrumer 2000 40/F N N Excision R CD34þ NA
22 Fuksbrumer 2000 71/F N N Excision R CD34þ NA
23 Fuksbrumer 2000 80/M N N No Excision R CD34þ NA
24 Yilmaz 2000 25/F Y þ Metastasis N Excision R Vimentinþ 6M
25 Lin 2001 75/M N N Excision R CD34þ 11M
26 Saint Marc 2002 69/F N N Excision R CD34þ 15M
27 Neeff 2004 63/F N N Excision L CD34þ 11M
28 Chithriki 2004 75/F N Y Excision R CD34þ 6M
29 Venarecci 2005 65/F N N Excision R CD34þ 30M
30 Ji 2006 46/F N N Excision R CD34þ NA
31 Lehmann 2006 63/F N N Excision R CD34þ 96M
32 Nath 2006 65/F N N Excision R CD34þ 10M
33 Terkivatan 2006 74/M N N Excision L CD34þ 12M
34 Weitz 2007 NA N N Excision NA NA NA
35 Weitz 2007 NA N N No Excision NA NA NA
36 Weitz 2007 NA N N No Excision NA NA NA
37 Obuz 2007 52/M N N Excision L CD34þ 22M
38 Perini 2007 40/F N N Excision L CD34þ 49M
39 Chan 2007 70/M Y þ Metastasis Y Excision R CD34þ 12M
40 Fama 2007 68/M N Y Excision R CD34þ 25M
41 Kwasky 2007 46/F N N Excision R CD34þ NA
42 Kandpal 2007 45/F N N No Excision R CD34þ NA
43 Korkolis 2008 82/F N N Excision L CD34þ 21M
44 Chen 2008 71/M N N Excision R CD34þ 9M
45 Novais 2008 34/F N N Excision R CD34þ 4Y
46 Taboada 2010 NA NA NA NA NA NA NA
47 Brochard 2010 54/M Y þ Metastasis N Excision R CD34þ 6Y
48 Peng 2011 24/F Y þ Metastasis N Excision R CD34þ 16M
49 Kesun 2011 59/M N N Excision L CD34þ 24M
50 Huanca 2011 52/NA N N Excision R CD34þ NA
51 Arredondo 2011 NA NA NA NA NA NA NA
52 Patra 2012 34/F N N Excision L CD34þ 4Y
53 Radunz 2012 85/F N Y Excision L CD34þ NA
54 Belga 2012 66/F N N Excision R CD34þ 2Y
55 Morris 2012 NA/F N N Excision R CD34þ 8M
56 Soussan 2013 64/M N N Excision L CD34þ NA
57 Liu 2013 42/M N N Excision L CD34þ NA
58 Jacob 2013 62/F Y N Excision L CD34þ NA
59 Present Case 1 2013 65/M N N Excision L CD34þ 12M
60 Present Case 2 2013 87/F N N No Excision R CD34þ 10M
61 Song 2014 49/M Y N Excision R CD34þ NA
F female; M male; Y yes; N no; Left; R right; M months; A years; NA not available; IH immunohistochemistry.
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cytokeratin-positive). However, the CD34 antibody is not speciﬁc
for SFT diagnosis and can be positive in angiosarcomas and
gastrointestinal stromal tumors, but it remains highly characteristic
of SFT [8e11]. Biopsies might not be accurate to conﬁrm a diagnosis
because it is possible that benign and malignant tissues are present
in the same lesion [11]. Fuksbrumer et al. [3] showed that malig-
nant foci discovered on the resected specimenwere not discovered
on the initial needle core biopsy.Therefore, a patient who only receive a needle core biopsy may
have a tumor that contains undiagnosed malignant components.
However biopsy might be helpful in cases where complete surgical
resection is not possible or when a preoperative diagnosis is
mandatory before surgery. Immunohistochemical study of the tis-
sues taken from the biopsy can direct toward a diagnosis of SFT.
These tumors might reach a very large size, and so at presentation,
secondary vascular or bile duct compression may occur, as seen in
some of the cases. The size and local invasion of these tumors to the
T. Debs et al. / International Journal of Surgery 12 (2014) 1291e12941294nearby vascular structures might lead to major hepatectomies,
even with extensive resections with high morbidities and high
mortalities [1,5,7,10]. The main concern in such cases is that SFT can
developmalignant transformation [11]. It is possible that malignant
and benign areas are present in the same lesion. The hyper-
cellularity, nuclear atypia, necrosis and high mitotic activity
(greater than 4 mitoses-ten high-power ﬁelds) are criteria used to
diagnose malignancy. Larger tumors (>10 cm) are correlated with
lower disease-free metastasis survival. Necrotic areas should alert
the physician to the possibility of atypical features or malignant
transformation, and biopsy may not identify a malignant compo-
nent in the sample taken [8e11].
Six cases of malignant liver SFT, with 4 of them giving rise to
metastases have been reported (Table 2). Brochard et al. [8] re-
ported a 54-year-man with a right hepatic tumor that was surgi-
cally resected. Local recurrence occurred 6 years later, and it was
resected. 2 years later, the patient developed metastasis to the
cranial base, and he died a few months after [8]. Chan et al. [9]
reported a 70-year-old man who presented with an SFT. A core
needle biopsy was in favor of SFT. Resection was performed. The
gross examination of the tumor revealed an SFT surrounded by a
high grade ﬁbrosarcoma. One year later, disseminated metastasis
developed [9]. Peng et al. [12] presented a 24-year-old womanwith
a 30 cm mass in the right liver with skull base parietal metastasis.
Extended right hepatectomy was performed and craniotomy was
performed 13 days later. Pathological examination showed skull
base metastases from a malignant solitary ﬁbrous tumor of the
liver. The tumor recurred in the residual liver 2 months after the
operation, and lumbar vertebra metastasis 7 months after the
operation paralyzed the patient. The patient died of uncontrolled
tumor 16 months after the initial operation [12]. Yilmaz et al. [13]
reported a 25-year-old woman who underwent right trisectionec-
tomy for a liver mass. At follow-up one month later, the patient had
severe back and waist pain. Metastatic osteoblastic lesions of the
thoracic and lumbar vertebraewere identiﬁed on x-ray and CT scan.
Biopsies of the left humerus and sternum revealed tumor
destruction of bone by cells similar to that of the liver tumor. No
follow up of the patient is available [13]. Jacob et al. [14] and Song
et al. [15] reported 2 cases of malignant SFT of the liver without any
distant metastasis. Surgical resection was performed; however no
information regarding the follow up is available.
These 6 cases represent around 10% of SFT cases. The risk of
malignancy is not extremely low, so it should always be kept in
mind that SFT carries a real risk of malignant transformation
[11e16].
In conclusion, it is difﬁcult to differentiate benign from malig-
nant tumors based only on imaging studies and biopsies. The nat-
ural history of the disease is unknown. These tumors can grow to
large sizes and remain benign in nature. As these tumors can
develop malignant transformation and they have the ability to
spread and metastasize, surgical resection remains the optimal
treatment, despite extensive surgery is needed to resect these tu-
mors with clear margins. Complete surgical resection with clear
margins remains the preferred treatment of choice. A correct
interpretation should be done on the pathological andTable 2
Summary of the 6 cases of malignant liver SFT.
Sex 3 Male; 3 Female
Age (years) Mean 47; Range 24e70
Liver 5 Right; 1 Left
Metastasis 4 out of 6 patients (66%)
Hypoglycemia 1/6 (17%)
Treatment 6/6 Excisionimmunohistochemical markers for an appropriate diagnosis.
However, it is difﬁcult to determine the long term prognosis of this
entity because of the small number of patients and the absence of
long term follow up, which does not allow us to draw any mean-
ingful conclusions regarding the clinical course of these tumors,
particularly in those cases in which we observed atypical features.
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